{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T17:21:08Z","timestamp":1786296068079,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.phrs.2023.106861","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T02:18:17Z","timestamp":1689819497000},"page":"106861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Degradation of MK2 with natural compound andrographolide: A new modality for anti-inflammatory therapy"],"prefix":"10.1016","volume":"194","author":[{"given":"Quy T.N.","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis X.L.","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wupeng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Keung","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L.L.","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.S. Fred","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2023.106861_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.635636","article-title":"The p38MAPK-MK2 signaling axis as a critical link between inflammation and synaptic transmission","volume":"9","author":"Beamer","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.phrs.2023.106861_bib2","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.bcp.2010.06.021","article-title":"MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin","volume":"80","author":"Ronkina","year":"2010","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.phrs.2023.106861_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13046-019-1115-1","article-title":"MAPKAPK2: the master regulator of RNA-binding proteins modulates transcript stability and tumor progression","volume":"38","author":"Soni","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2023.106861_bib4","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1093\/emboj\/18.18.4969","article-title":"The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism","volume":"18","author":"Winzen","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2023.106861_bib5","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1128\/MCB.26.6.2399-2407.2006","article-title":"Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine\/uridine-rich element","volume":"26","author":"Hitti","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.phrs.2023.106861_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/10061","article-title":"MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis","volume":"1","author":"Kotlyarov","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phrs.2023.106861_bib7","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4049\/jimmunol.177.3.1913","article-title":"MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis","volume":"177","author":"Hegen","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2023.106861_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017791","article-title":"MK2-deficient mice are bradycardic and display delayed hypertrophic remodeling in response to a chronic increase in afterload","volume":"10","author":"Ruiz","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.phrs.2023.106861_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1097-2765(05)00014-6","article-title":"Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development","volume":"2000","author":"Adams","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2023.106861_bib10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.191.5.859","article-title":"Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells","volume":"191","author":"Allen","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2023.106861_bib11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/MCB.01456-06","article-title":"The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK","volume":"27","author":"Ronkina","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.phrs.2023.106861_bib12","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.4049\/jimmunol.168.9.4667","article-title":"Mitogen-activated protein kinase-activated protein kinase 2-deficient mice show increased susceptibility to Listeria monocytogenes infection","volume":"168","author":"Lehner","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2023.106861_bib13","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1093\/emboj\/cdg552","article-title":"Feedback control of the protein kinase TAK1 by SAPK2a\/p38alpha","volume":"22","author":"Cheung","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2023.106861_bib14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ceb.2009.01.015","article-title":"Targeting protein kinases for the development of anti-inflammatory drugs","volume":"21","author":"Cohen","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.phrs.2023.106861_bib15","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/ni.1644","article-title":"The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling","volume":"9","author":"Ananieva","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2023.106861_bib16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/14728222.12.8.921","article-title":"MK2: a novel molecular target for anti-inflammatory therapy","volume":"12","author":"Duraisamy","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.phrs.2023.106861_bib17","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1016\/j.bmcl.2009.02.017","article-title":"Benzothiophene inhibitors of MK2. Part 2: improvements in kinase selectivity and cell potency","volume":"19","author":"Anderson","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phrs.2023.106861_bib18","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.bmcl.2009.10.138","article-title":"Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategy","volume":"20","author":"Velcicky","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phrs.2023.106861_bib19","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1016\/j.bmcl.2008.10.039","article-title":"Pyrrolo-pyrimidones: a novel class of MK2 inhibitors with potent cellular activity","volume":"18","author":"Schlapbach","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"13","key":"10.1016\/j.phrs.2023.106861_bib20","first-page":"123","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of the MK2 inhibitor ATI-450 in healthy subjects: a placebo-controlled, randomized phase 1 study","volume":"2021","author":"Gordon","year":"2021","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.phrs.2023.106861_bib21","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3390\/ph15121508","article-title":"MK2 inhibitors as a potential Crohn's disease treatment approach for regulating MMP expression, cleavage of checkpoint molecules and T cell activity","volume":"15","author":"Lebish","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.phrs.2023.106861_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.trsl.2022.06.005","article-title":"Discovery of CC-99677, a selective targeted covalent MAPKAPK2 (MK2) inhibitor for autoimmune disorders","volume":"249","author":"Malona","year":"2022","journal-title":"Transl. Res."},{"key":"10.1016\/j.phrs.2023.106861_bib23","first-page":"PA4649","article-title":"MAPKAP kinase 2 (MK2) expression is associated with severe asthma","volume":"48","author":"Chupp","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2023.106861_bib24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ptr.7324","article-title":"Andrographolide: a review of its pharmacology, pharmacokinetics, toxicity and clinical trials and pharmaceutical researches","volume":"36","author":"Zeng","year":"2022","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2023.106861_bib25","first-page":"4510591","article-title":"Cost-effectiveness analysis of Xiyanping injection (andrographolide sulfonate) for treatment of adult community acquired pneumonia: a retrospective, propensity score-matched cohort study","author":"Shi","year":"2019","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.phrs.2023.106861_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcp.2017.03.024","article-title":"Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action","volume":"139","author":"Tan","year":"2017","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.phrs.2023.106861_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.phrs.2017.07.019","article-title":"Labdane diterpenoids as potential anti-inflammatory agents","volume":"124","author":"Tran","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2023.106861_bib28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/prot.20035","article-title":"GEMDOCK: a generic evolutionary method for molecular docking","volume":"55","author":"Yang","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.phrs.2023.106861_bib29","doi-asserted-by":"crossref","first-page":"10176","DOI":"10.1074\/jbc.M310486200","article-title":"MAPKAP kinase 2 phosphorylaes tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding","volume":"279","author":"Chrestensen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106861_bib30","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.celrep.2019.12.090","article-title":"Cross-talk between CD38 and TTP is essential for resolution of inflammation during microbial sepsis","volume":"30","author":"Joe","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2023.106861_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/d41573-021-00052-4","article-title":"Targeted protein degraders crowd into the clinic","volume":"20","author":"Mullard","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"118","key":"10.1016\/j.phrs.2023.106861_bib32","article-title":"MK2 degradation as a sensor of signal intensity that controls stress-induced cell fate","volume":"2021","author":"Gutierrez-Prat","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2023.106861_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.trsl.2015.12.002","article-title":"Andrographolide stimulates p38 mitogen-activated protein kinase-nuclear factor erythroid-2-related factor 2-heme oxygenase 1 signaling in primary cerebral endothelial cells for definite protection against ischemic stroke in rats","volume":"170","author":"Yen","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.phrs.2023.106861_bib34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12974-016-0723-3","article-title":"Andrographolide induces Nrf2 and heme oxygenase 1 in astrocytes by activating p38 MAPK and ERK","volume":"13","author":"Wong","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2023.106861_bib35","first-page":"829","article-title":"Andrographolide regulates phosphorylated p38 mitogen-activated protein kinases and phosphorylated ERK expression in spinal cord and reduces postoperative pain in rats","volume":"57","author":"Sridharan","year":"2022","journal-title":"Mater. Today: Proc."},{"key":"10.1016\/j.phrs.2023.106861_bib36","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1073\/pnas.0701679104","article-title":"Molecular basis of MAPK-activated protein kinase 2:p38 assembly","volume":"104","author":"White","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2023.106861_bib37","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1074\/jbc.M611165200","article-title":"Crystal structure of the P38\u03b1-MAPKAP kinase 2 heterodimer","volume":"282","author":"Haar","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106861_bib38","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.phrs.2023.106861_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112481","article-title":"From irreversible to reversible covalent inhibitors: harnessing the andrographolide scaffold for anti-inflammatory action","volume":"204","author":"Tran","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2023.106861_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.751313","article-title":"Conceptual advances in control of inflammation by the RNA-binding protein tristetraprolin","volume":"12","author":"Kovarik","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2023.106861_bib41","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1093\/emboj\/17.12.3363","article-title":"Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation","volume":"17","author":"Engel","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2023.106861_bib42","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0960-9822(98)70442-7","article-title":"Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2","volume":"8","author":"Ben-Levy","year":"1998","journal-title":"Curr. Biol."},{"key":"10.1016\/j.phrs.2023.106861_bib43","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1002\/art.34489","article-title":"Antiinflammatory functions of p38 in mouse models of rheumatoid arthritis: advantages of targeting upstream kinases MKK-3 or MKK-6","volume":"64","author":"Guma","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.phrs.2023.106861_bib44","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1084\/jem.20172063","article-title":"Selective inhibition of the p38\u03b1 MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signals","volume":"215","author":"Wang","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2023.106861_bib45","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.drudis.2013.02.010","article-title":"Pharmacokinetics and the drug-target residence time concept","volume":"18","author":"Dahl","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phrs.2023.106861_bib46","doi-asserted-by":"crossref","first-page":"15448","DOI":"10.1002\/anie.202004310","article-title":"Prey for the proteasome: targeted protein degradation a medicinal chemist's perspective","volume":"59","author":"Luh","year":"2020","journal-title":"Angew. Chem."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823002177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823002177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:49:06Z","timestamp":1760914146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823002177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":46,"alternative-id":["S1043661823002177"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106861","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Degradation of MK2 with natural compound andrographolide: A new modality for anti-inflammatory therapy","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106861"}}